ProPhase Labs, Inc. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
ProPhase Labs, Inc. (PRPH) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $54.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2017-08-11
- ProPhase Labs, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-06-30 was $0.00.
- ProPhase Labs, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-03-31 was $54.00K.
- ProPhase Labs, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-12-31 was $95.00K.
- ProPhase Labs, Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-09-30 was $0.00.
- ProPhase Labs, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2016 was $190.00K, a 3066.67% increase from fiscal 2015.
- ProPhase Labs, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $6.00K, a 40.00% decline from fiscal 2014.
- ProPhase Labs, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $10.00K, a 23.08% decline from fiscal 2013.
- ProPhase Labs, Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2013 was $13.00K.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $54.00K 10-Q · filed 2017-08-11 | $149.00K derived: sum of 3 quarters · filed 2017-08-11 | $149.00K derived: sum of 4 quarters · filed 2017-08-11 |
| 2017-03-31 | $54.00K 10-Q · filed 2017-05-15 | $149.00K derived: sum of 2 quarters · filed 2017-05-15 | $149.00K derived: sum of 3 quarters · filed 2017-05-15 | |
| 2016-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $95.00K derived: sum of 2 quarters · filed 2017-02-24 | $190.00K 10-K · filed 2017-02-24 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $95.00K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $95.00K 10-Q · filed 2017-08-11 | |||
| 2015-12-31 | $6.00K 10-K · filed 2017-02-24 | |||
| 2014-12-31 | $10.00K 10-K · filed 2017-02-24 | |||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | $13.00K 10-K · filed 2016-03-29 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-27 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |